Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...

Here we report a case of a T-cell lymphoma harboring a lentiviral integration ... immunosequencing of peripheral-blood and duodenal-biopsy samples at indicated days after chimeric antigen receptor ...

Diagnostic models were constructed through random forest algorithm and validated in subgroups. Results We determined the disturbance of systemic immunity caused by HCC and PDAC, and calculated a ...

The symptoms are largely due to the onset of anemia (characterized by the loss of red blood cells) and thrombocytopenia (the loss of blood-clotting ... Karen Raymaakers RN, CON(C) is a certified ...

peripheral T-cell lymphoma, mantle cell lymphoma, B-cell acute lymphoblastic leukemia (B-ALL), marginal zone b-cell lymphoma, soft tissue sarcoma, angioimmunoblastic T-cell lymphoma, large anaplastic ...

Peripheral T-cell lymphoma (PTCL) is an aggressive tumor derived from mature T cells and natural killer cells with an extremely poor prognosis. Ferroptosis is a mechanism of cell death that is ...

Camrelizumab is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Follicular Lymphoma ... anaplastic large cell lymphoma, advanced right-sided colon cancer, ...

Nodal marginal zone lymphoma (NMZL) is a rare type of non-Hodgkin lymphoma (NHL). It belongs to a group of non-Hodgkin lymphomas called marginal zone lymphomas (MZL). There are three types: nodal ...

Follicular lymphoma (FL) is a mature lymphoid malignancy derived from germinal center B cells, accounting for approximately 22% of all non-Hodgkin's lymphomas. It is common in middle-aged and older ...

Furthermore, the rate of serious adverse events, including myelotoxicity and peripheral neuropathy, did not differ statistically significantly ... such as R/R diffuse large B-cell lymphoma, follicular ...